Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)

NCT07303322 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

372

Enrollment

INDUSTRY

Sponsor class

Conditions

Female Pattern Hair Loss
Female Pattern Hair Loss, Androgenic Alopecia

Interventions

DRUG: N1087
DRUG: Placebo

Sponsor

Eurofarma Laboratorios S.A.